NFG
NYMX

Next Financial Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Next Financial Group’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,000
Closed -$5K – 2365
2016
Q4 		$5K Hold
2,000
– – ﹤0.01% 1948
2016
Q3 		$7K Hold
2,000
– – ﹤0.01% 1824
2016
Q2 		$6K Hold
2,000
– – ﹤0.01% 1383
2016
Q1 		$4K Hold
2,000
– – ﹤0.01% 1444
2015
Q4 		$6K Hold
2,000
– – ﹤0.01% 1352
2015
Q3 		$6K Buy
+2,000
New +$4.65K ﹤0.01% 1387

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

Next Financial Group's NYMX Position: Q1 2017 in Review

Next Financial Group sold out of Nymox Pharmaceutical Corp (NYMX) in Q1 2017, closing a stake of 2,000 shares — an estimated $5K sold.

Next Financial Group first reported a position in NYMX in Q3 2015 and held it in 6 quarters. The position peaked at $7K in Q3 2016. 29 funds tracked by Wall St. Rank hold NYMX as of Q1 2017.

  • Next Financial Group reported no remaining Nymox Pharmaceutical Corp position as of Q1 2017 after selling out during the quarter.
  • Next Financial Group sold 2,000 Nymox Pharmaceutical Corp shares in Q1 2017, an estimated $5K.
  • Next Financial Group first reported a position in Nymox Pharmaceutical Corp in Q3 2015 and held it in 6 quarters.
  • Next Financial Group's Nymox Pharmaceutical Corp position peaked at $7K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2017.

Based on Next Financial Group's 13F filing for Q1 2017, filed 8 May 2017.